羟氯喹视网膜病变的定量眼底自发荧光研究
结果显示15例高剂量患者中4例、16例低剂量患者中1例诊断为羟氯喹相关视网膜病变,部分患者qAF和NIR-AF异常。结论提示筛查羟氯喹视网膜病变时应考虑上下方易感性差异。
要点
- 高剂量组(总剂量>1000g,日剂量>5.0mg/kg)视网膜病变发生率高于低剂量组。
- qAF彩色编码图显示部分患者黄斑下方、鼻侧和颞侧强度增高。
- NIR-AF在无视网膜病变的高剂量患者中平均灰度强度增加,但在部分病变患者旁中心凹低于正常。
核心结论
- 筛查羟氯喹视网膜病变时应考虑上下方易感性差异。
研究设计与样本
- qAF测量采用内部荧光参考,在7°至9°偏心率的八个同心段进行强度测量;NIR-AF沿通过中心凹的垂直轴获取强度进行半定量分析。
主要发现
- 15例高剂量患者(总剂量>1000g,日剂量>5.0mg/kg)中4例、16例低剂量患者(总剂量<1000g,日剂量4.4mg/kg)中1例基于异常10-2视野、SD-OCT和SW-AF成像诊断为羟氯喹相关视网膜病变。
- 3例高剂量患者同时有异常mfERG结果;5例视网膜病变患者中2例qAF彩色编码图像显示黄斑下方、鼻侧和颞侧强度增高,异常视野也呈现上下方差异。
- 4例无视网膜病变证据的高剂量患者平均NIR-AF灰度强度增加;2例视网膜病变患者旁中心凹NIR-AF强度低于正常范围;1例高剂量患者(6.25mg/kg)仅有mfERG结果异常。
临床怎么用
- 在羟氯喹视网膜病变筛查中,应关注上下方视网膜的易感性差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To increase our understanding of the mechanisms underlying hydroxychloroquine (HCQ) retinopathy, analyses by quantitative fundus autofluorescence (qAF) and near-infrared fundus autofluorescence (NIR-AF) were compared to results obtained by recommended screening tests. METHODS: Thirty-one patients (28 females, 3 males) were evaluated with standard automated perimetry and spectral domain optical coherence tomography (SD-OCT); 28 also had multifocal electroretinography (mfERG). Measurement of short-wavelength fundus autofluorescence (SW-AF) by qAF involved the use of an internal fluorescent reference and intensity measurements in eight concentric segments at 7° to 9° eccentricity. For semiquantitative analysis of NIR-AF, intensities were acquired along a vertical axis through the fovea. RESULTS: Four of 15 high-dose (total dose >1000 g, daily dose >5.0 mg/kg) patients and one of 16 low-dose (total dose <1000 g, daily dose 4.4 mg/kg) patients were diagnosed with HCQ-associated retinopathy based on abnormal 10-2 visual fields, SD-OCT, and SW-AF imaging. Three of the high-dose patients also had abnormal mfERG results. Of the five patients exhibiting retinopathy, two had qAF color-coded images revealing higher intensities inferior, nasal, and lateral to the fovea. The abnormal visual fields also exhibited superior-inferior differences. Mean NIR-AF gray-level intensities were increased in four high-dose patients with no evidence of retinopathy. In two patients with retinopathy, NIR-AF intensity within the parafovea was below the normal range. One high-dose patient (6.25 mg/kg) had only abnormal mfERG results. CONCLUSIONS: These findings indicate that screening for HCQ retinopathy should take into consideration superior-inferior differences in susceptibility to HCQ retinopathy.
引用
- Greenstein VC, Lima de Carvalho JR, Parmann R, et al. Quantitative Fundus Autofluorescence in HCQ Retinopathy. Invest Ophthalmol Vis Sci. 2020. PMID: 32976563. doi:10.1167/iovs.61.11.41
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。